Axcella Health Inc. - Common Stock (NQ:AXLA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 22, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axcella Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗

December 16, 2022

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 16, 2022

Via Benzinga

Axcella Therapeutics Puts Development Of NASH Program Aside, Reduces Workforce By 85% ↗

December 15, 2022

Via Benzinga

Recap: Axcella Health Q3 Earnings ↗

November 01, 2022

Axcella Health (NASDAQ:AXLA) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Axcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial ↗

September 29, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 ↗

December 16, 2022

Via Benzinga

Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session ↗

December 15, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

Axcella Health: Q2 Earnings Insights ↗

August 12, 2022

Axcella Health (NASDAQ:AXLA) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 15, 2022

Via Benzinga

Axcella Announces Program Reprioritization and Corporate Restructuring

December 14, 2022

From Axcella Therapeutics

Via Business Wire

Axcella to Present at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting

November 03, 2022

From Axcella Therapeutics

Via Business Wire

Axcella Reports Third Quarter Financial Results and Provides Business Update

November 01, 2022

From Axcella Therapeutics

Via Business Wire

Axcella Therapeutics to Report Third Quarter 2022 Financial Results on November 1, 2022

October 27, 2022

From Axcella Therapeutics

Via Business Wire

$6 Million Bet On This This Stock? Check Out These 3 Penny Stocks Insiders Are Buying ↗

October 18, 2022

Gold futures traded slightly lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Axcella Therapeutics to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference

October 14, 2022

From Axcella Therapeutics

Via Business Wire

Axcella Therapeutics Announces $34.2 Million Registered Direct Offering of Common Stock Priced At The Market: Appoints Two New Board Members

October 13, 2022

From Axcella Therapeutics

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 06, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.

Via Benzinga

Looking Into Axcella Health's Recent Short Interest ↗

October 05, 2022

Axcella Health's (NASDAQ:AXLA) short percent of float has risen 18.87% since its last report. The company recently reported that it has 113 thousand shares sold short, which is 0.63% of all regular...

Via Benzinga

Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday ↗

October 03, 2022

Goldman Sachs raised Wells Fargo & Company (NYSE: WFC) price target from $46 to $48. Goldman Sachs analyst Richard Ramsden upgraded the stock from Neutral to Buy. Wells Fargo shares rose 1.1% to $40.68...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 30, 2022

Gainers Ainos (NASDAQ:AIMD) shares increased by 46.4% to $2.02 during Friday's pre-market session. The market value of their outstanding shares is at $39.3 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 29, 2022

Good morning! We're taking a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

Axcella Announces Positive Interim Data from Phase 2b EMMPACT Study of AXA1125 in Nonalcoholic Steatohepatitis (NASH)

September 29, 2022

From Axcella Therapeutics

Via Business Wire

Peering Into Axcella Health's Recent Short Interest ↗

September 19, 2022

Axcella Health's (NASDAQ:AXLA) short percent of float has fallen 8.62% since its last report. The company recently reported that it has 96 thousand shares sold short, which is...

Via Benzinga

Axcella Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

September 12, 2022

From Axcella Therapeutics

Via Business Wire

Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday ↗

September 20, 2022

Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 12, 2022

Via Benzinga

Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session ↗

September 19, 2022

Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.

Via Benzinga

Axcella Reports Second Quarter Financial Results and Provides Business Update

August 12, 2022

From Axcella Therapeutics

Via Business Wire

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 02, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.